505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. in FDA
Similar to 505(b)(2)
ACOL - Acceptable Carry-Over LimitACPE - Accreditation Council for Pharmacy Education
ACPM - American College of Preventive Medicine
ACR - American College of Radiology
ACRA - Associate Commissioner for Regulatory Affairs
ACS - Automated Commercial System
ACS (CBER) - Analytical Chemistry Staff CBER
View all in FDA